How has HURA's R&D spending trend impacted its operating profit in Q1 2025?

HURA's R&D spending trend has had a significant negative impact on its operating profit in Q1 2025. The company's R&D expenses were $1.86 million during the quarter, while its operating income was -$2.96 million. This indicates that the company's operating profit was deeply in the red, and the high level of R&D spending is a major factor contributing to this loss. |code|Ticker|Name|Date|R&D Expenses|Operating Income|market_code| |---|---|---|---|---|---|---| |HURA|HURA.O|TuHURA Biosciences|2024 Q2|111000|-1017000|186| |HURA|HURA.O|TuHURA Biosciences|2024 Q3|592000|-2011000|186| |HURA|HURA.O|TuHURA Biosciences|2024 Q4|101000|-2324000|186| |HURA|HURA.O|TuHURA Biosciences|2025 Q1|252000|-2160000|186|